文献速递乳腺乳腺X线US

在一站式即时阅片乳腺筛查中,用二维数字乳腺X线摄影时,以MLO断层摄影投影及其合成视图替代二维数字MLO投影是否有附加价值

Is there any added value to substitute the 2D digital MLO projection for a MLO tomosynthesis projection and its synthetic view when a 2D standard digital mammography is used in a one-stop-shop immediate reading mammography screening?
PubMed 文献 · Eur Radiol · 2021-05-28

该回顾性观察研究比较了13,048名接受DM筛查的女性与8,639名接受SM-DBT/DM筛查的女性,发现在一站式即时阅片筛查中,用DBT-MLO及SM-MLO替代2D-MLO可显著提高总体癌症检出率(10.8‰ vs 7.5‰,p=0.0120),但伴随更多超声检查、活检和BI-RADS III类病变。

要点

  • SM-DBT/DM方案较DM方案显著提高总体癌症检出率(10.8‰ vs 7.5‰,p=0.0120)。
  • SM-DBT/DM组浸润性小叶癌检出比例更高(14% vs 4%,p=0.0357)。
  • SM-DBT/DM组伴随更多超声检查(33.5% vs 26.7%)、活检(3.0% vs 1.7%)和BI-RADS III类病变(1.8% vs 1.5%)。

核心结论

  • 在一站式即时阅片筛查中,以DBT-MLO和SM-MLO替代2D-MLO的混合乳腺摄影方案提高了癌症检出率,但代价是更多超声检查、活检和BI-RADS III类病变;单纯乳腺超声在该队列中检出全部乳腺癌的9.2%。

研究设计与样本

  • 回顾性观察性阅片研究,比较2015年6月至2016年11月接受DM筛查的13,048名女性和2017年1月至2018年7月接受SM-DBT/DM筛查的8,639名女性,采用卡方检验或Fisher精确检验比较两种筛查成像方法的比例。

关键影像表现/征象

  • SM-DBT/DM组总体癌症检出率为10.8‰,DM组为7.5‰(p=0.0120)。
  • SM-DBT/DM组浸润性小叶癌占14%,DM组占4%(p=0.0357)。
  • 乳腺密度B型女性中SM-DBT/DM组总体浸润性癌更多(p=0.0411)。
  • 60至70岁女性中SM-DBT/DM组总体浸润性癌更多(p=0.0306)。
  • SM-DBT/DM组BI-RADS III类病变占1.8%,DM组占1.5%(p=0.0443)。

诊断标准与关键数值

  • SM-DBT/DM组超声检查率为33.5%,DM组为26.7%(p<0.0001)。
  • SM-DBT/DM组活检率为3.0%,DM组为1.7%(p<0.0001)。
  • 单纯乳腺超声在该队列中检出全部乳腺癌的9.2%。

临床应用与阅片要点

  • 作者认为,基于本研究结果,MLO平面采用DBT+SM、CC平面采用DM的混合方案可安全实施,作为向单独使用DBT和SM过渡的方案,而不损害癌症检出能力。
  • 作者指出,其结果可能因不同厂商机器的性能而异。

局限性

  • 作者指出,其结果可能因不同厂商机器的性能而异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Breast cancer screening consists of batch interpretation of two-view (cranio-caudal CC- and medio-lateral oblique MLO) digital mammography (DM) per breast. The DM-MLO view was substituted by an MLO-digital breast tomosynthesis (DBT) and its synthetic (2D-synthetic mammography (SM)-MLO) view. The performance of this hybrid protocol was evaluated in a one-stop-shop screening visit, providing immediate reading and additional work up.

METHODS: Retrospective, observational review, comparing the cancer detection rate (CDR), breast US rates, and biopsy rates in 13,048 women screened with DM from June 2015 to November 2016 and 8639 women screened with SM-DBT/DM from January 2017 to July 2018. Chi-square tests or Fisher's exact tests were used to compare proportions between the two screening imaging methods.

RESULTS: SM + DBT/DM significantly increased the overall CDR (10.8‰) versus DM (7.5‰) (p = 0.0120) with more invasive lobular carcinoma (14% versus 4%) (p = 0.0357) detected and overall more invasive cancers among women with breast density type B (p = 0.0411) and those aged between 60 and 70 (p = 0.0306). This was achieved at the expense of additional sonographic examinations performed (33.5% in DBT group versus 26.7% in DM group) (p < 0.0001), more BI-RADS category III assigned (1.8% in SM-DBT/DM group versus 1.5% in DM group) (p = 0.0443) and more biopsy rates (3.0 % in SM-DBT/DM group versus 1.7% in DM group) (p < 0.0001).

CONCLUSIONS: Hybrid mammographic protocol replacing 2D-MLO by DBT-MLO and SM-MLO views in a one-stop-shop screening visit improved CDR, at the expense of more sonographic examinations, biopsies, and BI-RADS III lesions. Breast US alone detected 9.2% of all breast cancers in this cohort.

KEY POINTS: • Hybrid protocol including MLO (DBT + SM) with 2D DM CC may improve CDR compared to standard 4 views 2D DM in a screening program providing immediate interpretation. • Adding screening breast US, when perceived necessary, in the same visit of a screening mammography, increases cancer detection rate of 9.2%. • Based on our results, hybrid protocol including DBT + SM in MLO plane and DM in CC plane could be safely implemented as a transition towards DBT and SM alone, without any compromise in the cancer detection ability. Our results may vary according to the properties of machines from different vendors.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Mesurolle B, El Khoury M, Travade A, et al. Is there any added value to substitute the 2D digital MLO projection for a MLO tomosynthesis projection and its synthetic view when a 2D standard digital mammography is used in a one-stop-shop immediate reading mammography screening? Eur Radiol. 2021. PMID: 34047846. doi:10.1007/s00330-021-07999-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。